Results 81 to 90 of about 252,536 (246)

Chronic Respiratory Diseases in the 2023‐Defined WHO Western Pacific Region: Burden and Trends From GBD 2023

open access: yesMed Research, EarlyView.
Chronic respiratory disease burden in the 2023‐defined WHO Western Pacific Region, 1990–2023: Using the Global Burden of Disease 2023 estimates, this study characterized the incidence, prevalence, deaths, and disability‐adjusted life years (DALYs) associated with chronic respiratory diseases (CRDs) in the 37 WHO Western Pacific Region Member States and
Zhang Yue   +7 more
wiley   +1 more source

Quality-of-Life Assessment in Children with Mild to Moderate Bronchial Asthma

open access: yesMedicina
Background and Objectives: Assess the quality of life of children aged 2–10 with mild to moderate bronchial asthma. To evaluate the general health condition of children with mild and moderate severity bronchial asthma.
Agnė Čibirkaitė   +4 more
doaj   +1 more source

Pharmacological treatment of bronchial asthma: Dental implications

open access: yes, 2020
This thesis is dealing with a description of the pathology of bronchial asthma and the possible therapies. These include non-pharmacological solutions like speleotherapy and treatment with a wide variety of drugs. Special attention is paid to the adverse
van der Veen, Daniel Constantijn
core  

長期間喫煙による気管支唱息,肺気腫の病態的変化 [PDF]

open access: yes, 2004
The influence of long-term cigarette smoking on the pathophysiology of chronic respiratory diseases with obstructive ventilatory dysfunction was discussed in patients with asthma and pulmonary emphysema (PE). 1.
Hosaki, Yasuhiro   +7 more
core   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai   +4 more
wiley   +1 more source

Glucocorticoids Impair the Airway Epithelial Barrier via Autophagy‐Associated Apoptosis in Asthma: A Preliminary Study Both In Vitro and In Vivo

open access: yesPediatric Discovery, EarlyView.
Mechanism underlying the negative effects of glucocorticoids on the airway epithelial barrier. Glucocorticoids upregulate autophagy factors and downregulate anti‐autophagy factors. Enhanced autophagy promotes excessive apoptosis and epithelial detachment, impairing airway barrier function.
Hao You   +10 more
wiley   +1 more source

Bronchial asthma in childhood: pathophysiology and treatment

open access: yes, 2020
Bronchial asthma is the most common disease of childhood.
Vilbergsdóttir, Sandra Yr
core  

Anticholinergic therapy for acute asthma in children. [PDF]

open access: yes, 2012
Inhaled anticholinergics as single agent bronchodilators (or in combination with beta(2)-agonists) are one of the several medications available for the treatment of acute asthma in ...
Acworth, Jason P.   +16 more
core   +1 more source

Immunomodulatory Properties of Withania somnifera: Regulation of Innate Immune Cells and Clinical Implications

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Withania somnifera (L.) Dunal (WS), commonly known as Ashwagandha, is a prominent medicinal herb in Ayurveda, with extensive therapeutic potential attributed to its diverse phytochemical profile. This review critically examines the immunomodulatory properties of WS, focusing on innate immune cell populations, including neutrophils, eosinophils,
Rana Yukta   +9 more
wiley   +1 more source

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy